Evonik Industries : Roadshow Präsentation

€15.3 bn

Sales

€1.7 bn (10.8%)

Adj. EBITDA (margin)

€801 m (48%)

Free Cashflow (conversion)

€1.17 (>6%)

Dividend (yield)

LEADING

BEYOND

CHEMISTRY

Specialty

Additives

Small amount - big effect

Nutrition & Care

Life at heart. Systems in mind. Partners at hand.

Smart Materials

We find solutions for the needs

of today and tomorrow

ENSURE HEALTH

SPECIALTY ADDITIVES

for environmentally-friendly solutions, e.g. water-based artificial leather

CIRCULAR ECONOMY

Lightweight solutions

Solutions for hybrid & full battery cars

Circular plastic &

PU additive solutions

Specialty hydrogen peroxides solutions

DRIVE

CIRCULARITY

BIO-BASED SOLUTIONS

Bio-based & fully biodegradable surfactants

Natural active cosmetics ingredients

Omega-3 fatty acids from natural marine algae

Gut health solutions

SAFEGUARD

ECOSYSTEMS

Three major strategic levers…

Next Generation Portfolio

Exit Performance Materials division

Full focus on three attractive growth divisions

Next Generation Innovation

€1 bn new sales from Innovation Growth Fields by 2025 driven by new products such as membranes or rhamnolipids

… with sustainability fully integrated …

Sustainability

Innovation

Portfolio

… delivering on ambitious targets

ESG Targets1

>50% sales share of

-25% CO2 emission reduction, e.g. via

Financial Targets

Organic growth >4%

Next Generation Culture

Culture

Employee empowerment ("Evonik Tailor Made")

ESG targets integrated into mgmt. compensation

1. Until 2030

5 March / April 2024 | Evonik Q4 / FY 2023 Company Presentation

EBITDA margin 18-20%

ROCE ~11%

FCF Conversion >40%

Innovation Growth Fields (sales in € m)

Cosmetic Solutions

• Expanding portfolio of innovative active cosmetic ingredients

Healthcare Solutions

• e.g. lipids for mRNA-based therapies
• US production facility under construction

Membranes

• For separation of biogas or the extraction of hydrogen
• New capacities coming 2025

-25%

Portfolio Management

~43%

Next

Generation

Solutions

Portfolio aligned to

sustainability

Sales share with solutions with a clearly positive sustainability profile; target of >50% by 2030

Short-term

self-help measures

Mid-term strategy execution

Contingency measures in 2023 & 2024

Business optimization programs

NWC and capex discipline

Portfolio transformation Reorganization: Evonik Tailor Made Innovation and NGS growth

Earnings growth in 2024

Sustainably strong cash generation

Attractive & reliable dividend

Green transformation of portfolio and production

Innovation for future growth

Short-term

self-help

measures

Contingency measures in 2023 & 2024:

€250 m savings to safeguard financial performance